Protein power: Synthetic biology company Absci prices IPO at $16 midpoint, Absci, which provides a platform for the discovery and development of protein therapies, raised $200 million by offering 12.5 million shares at $16, the midpoint of the $15 to $17 range.AbSci states that its Integrated Drug Creation Platform uses synthetic biology technologies an,

Absci, which provides a platform for the discovery and development of protein therapies, raised $200 million by offering 12.5 million shares at $16, the midpoint of the $15 to $17 range.AbSci states that its Integrated Drug Creation Platform uses synthetic biology technologies an

, , Renaissance Capital, {authorlink}, https://www.nasdaq.com/articles/protein-power:-synthetic-biology-company-absci-prices-ipo-at-%2416-midpoint-2021-07-22, https://www.nasdaq.com/feed/rssoutbound?category=IPOs, IPOs Feed,

This feed is responsible for generating the rss feed related to the topic ipos

, , IPO Calendar, 45, July 22, 2021, 12:21 am

By A Silva

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.